Korea

IMBdx Expands Targeted Therapies Agreement Following Successful Evaluation of Blood-Based Genomic Profiling Assay in Prostate Cancer

SEOUL, South Korea, June 8, 2023 /PRNewswire/ -- IMBdx Inc., a premier precision cancer diagnostic company accredited by CAP, announced today its plans to broaden its collaboration with AstraZeneca, a leading global biopharmaceutical company. This expansion will advance the shift from tissue to ...

2023-06-08 20:00 2304

SK networks Invests $2M in AI Farming Startup 'Source.ag'

* AI-powered Optimization of Farming Methods and Projected Yields: Pioneering Innovation in Greenhouse Agriculture * Strategic Investment Driven by Growth Potential in Smart Farm Market and Scalability of Technology * SK networks' Commitment to Strengthen Sustainability, DT, and Web3 in Line...

2023-06-08 09:03 2876

ITIMES: Incheon Mayor Yoo Jeong-bok "Overseas Korean Network Hub Will Help Incheon Grow as a Global City"

INCHEON, South Korea, June 7, 2023 /PRNewswire/ -- On June 5, 2023, the opening ceremony of the Overseas Korean Affairs Office was held in Incheon,South Korea. President Yoon Suk-Yeol...

2023-06-07 14:39 2173

Deep In Sight unveils groundbreaking AI-powered 3D depth sensing solutions at CommunicAsia 2023

* Showcasing In-Cabin Monitoring solution and Volume Management System which are Deep-In-Sight's cutting-edge 3D Sensing solutions at CommunicAsia 2023 * Deep-In-Sight's solutions are expected to meet the diverse demands in the growing global robotics, mobility, and smart factory sectors. SEOU...

2023-06-06 20:00 1935

Samsung Biologics accelerates timeline of new fifth plant to be operational by April 2025

- Marking the first phase of the company's second Bio Campus, Plant 5 is expected to have shortest construction timeline - Samsung Biologics will maintain the world's largest biomanufacturing capacity at 784,000 liters upon completion of the newest plant - Key features of Plant 5 include seamless ...

2023-06-06 19:00 2227

Lunit and Capio S:t Göran Hospital Collaborate to Address Radiologist Shortage with AI-Powered Mammography Analysis

- Lunit and Sweden's largest private hospital pioneering a new approach to combine radiologists' expertise with AI SEOUL, South Korea, June 5, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading global provider of AI-powered cancer diagnostic solutions, today announced the signing of a supply ...

2023-06-05 15:00 2071

Gencurix Announces Clinical Research Results At ASCO 2023 Demonstrating Outstanding Performance of GenesWell BCT, the Company's Breast Cancer Prognostic Test, Compared to Global Best-Selling Test, OncotypeDX

SEOUL, South Korea, June 4, 2023 /PRNewswire/ -- Gencurix (KOSDAQ #229000), a leading provider of cancer molecular diagnostics, announced the release of clinical research results directly comparing the accuracy of its breast cancer prognostic test, GenesW...

2023-06-05 14:37 2765

LOTTE BIOLOGICS to Kick off their CDMO Business Campaign at 'BIO International Convention 2023'

* Exclusive booth and private meeting rooms to be utilized for robust business initiatives SEOUL, South Korea, June 4, 2023 /PRNewswire/ -- LOTTE BIOLOGICS, under the leadership of CEORichard Lee, enthusiastically disclosed its participation in the upcoming 'BIO International Convention 2023' t...

2023-06-05 08:27 2223

GC Biopharma receives a business license for the construction of a plasma fractionation plant and technology transfer in Indonesia

* In recognition of securing high-caliber technology in manufacturing plasma derivatives and a track record of overseas plasma fractionation plant construction and technology transfer YONGIN, South Korea, June 1, 2023 /PRNewswire/ -- GC Biopharma, a South Korean biopharmaceutical company, anno...

2023-06-02 08:35 2294

BIORCHESTRA Invited to Present Update on Central Nervous System Lead Program (BMD-001) and IV-Formulated siRNA Data at BIO2023 International Conference

* Presentation:"Successfully Achieving Intravenous (IV)-formulated RNA Delivery to the Brain, Evidence of Efficacy" scheduled for June 08, 2023, 12:00 p.m. ET, Room 104A * Pioneering IV-formulated inert drug delivery platform targeting neurodegenerative diseases * Lead program (BMD-001) adv...

2023-06-01 20:00 2224

Seegene Obtains IVDR Certification for 30 Diagnostic Assays

* Seegene certifies diagnostic assays for digestive, respiratory, women's diseases, and human papillomavirus to meet IVDR requirements * New regulation sets improved standards to ensure higher level of quality, safety, and reliability SEOUL, South Korea, June 1, 2023 /PRNewswire/ -- Seegene I...

2023-06-01 19:00 2084

Hyundai Mobis breaks ground in Indonesia for a New Battery System Plant

* Hyundai Mobis held a groundbreaking ceremony for global EV dedicated battery system plant, attended by 150 guests including local government officials on 31. * The new plant to supply battery systems for local flagship models in the first half of 2024, completing an EV ecosystem that covers...

2023-06-01 09:17 2756

SK networks Hico Capital to Collaborate with Bow Capital on Investment Opportunities in the Global Tech Sector

* SK networks to collaborate with Bow Capital Management, LLC ("Bow Capital"), a venture capital fund formed by Vivek Ranadivé, Silicon Valley Veteran and NBA Team Owner * Collaboration to harness Hico Capital's Expertise to Propel SK networks Global VC Expansion * "Leveraging Investment Pr...

2023-05-31 13:13 2432

Yuhan Corporation and J INTS BIO inked a licensing agreement for a New Drug Candidate targeting HER2 NSCLC

SEOUL, South Korea, May 31, 2023 /PRNewswire/ -- Yuhan Corporation (CEO, Wook-Je Cho) announced on the 30th of May that it has signed an in-license agreement with J INTS BIO (CEO,Anna Jo) for a Tyrosine Kinase Inhibitor (TKI) targeting HER2, 'JIN-A04'. The total contract size is325 million dollar...

2023-05-31 13:02 1658

STRADVISION to open new 'Autonomous Driving Workshop' in Dongtan, Korea

* New workshop establishes an optimal test environment for object recognition solutions to improve SVNet performance and strengthen R&D capabilities * Dongtan metropolitan location strengthens accessibility to the test center, where timely support for clients is available SEOUL, South Korea, M...

2023-05-30 23:00 2431

Boryung Partners with Axiom Space and Aurelia Institute to Launch the "2023 Humans In Space" Program

* "Humans In Space" program co-hosted by Boryung, Axiom Space and Aurelia Institute to explore three interdisciplinary pillars of healthcare, lifestyle, and platform in hopes of shaping the future of interplanetary civilization. * Boryung aims to expand the space healthcare ecosystem, establis...

2023-05-30 21:00 2235

Lunit and the Japan National Cancer Center Hospital East Partner in AI Pathology to Advance Precision Oncology

* Collaborative research with Japan's largest oncology practice shows Lunit SCOPE's potential in predicting clinical outcomes for rectal cancer SEOUL, South Korea, May 30, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a global provider of AI-powered cancer diagnostic solutions, today announced c...

2023-05-30 20:00 2058

iNtRON identifies Prophage and Jamphage in the Pancreatic cancer related Microbiome

* It was confirmed the presence of Prophage and Jamphage in the Alkalihalobacillus clausii * Prophage and Jamphage are expected to play a substantial role in bacterial survival and immune regulation in the body. BOSTON and SEOUL, South Korea, May 29, 2023 /PRNewswire/ -- iNtRON Biotechnology ...

2023-05-30 10:15 1835

SK hynix Enters Industry's First Compatibility Validation Process for 1bnm DDR5 Server DRAM

* Offers fastest operating speed in DDR5 history, ultra-low power consumption with adoption of HKMG process * Expects to successfully complete validation of industry-leading 1bnm DDR5 * Mass production of industry's most advanced 1bnm DDR5 to help improve 2H23 earnings * 1bnm technology to...

2023-05-30 07:30 2420

Bridge Biotherapeutics to Present at the 2023 BIO International Convention

SEONGNAM, South Korea and CAMBRIDGE, Mass., May 29, 2023 /PRNewswire/ -- Bridge Biotherapeutics Inc. (KQ288330), a South Korean clinical-stage biotechnology company focused on developing novel drugs for cancer, fibrosis and inflammation, is scheduled to give a company presentation onTuesday, June...

2023-05-30 06:00 2266
1 ... 39404142434445 ... 111

Week's Top Stories